NEXGEL to Present at H.C. Wainwright's Bioconnect Conference

Rhea-AI Summary

NexGel, Inc. (NASDAQ: NXGL, NXGLW), based in Langhorne, Pa., specializes in high water-content hydrogels for healthcare and cosmetics. On January 4, 2022, it announced that CEO Adam Levy will present at the virtual H.C. Wainwright Bioconnect Conference from January 10-13, 2022. Levy's presentation will be available on-demand starting January 10th at 7:00 a.m. ET. For details, attendees can register here. NexGel has developed over 200 hydrogel combinations for gentle skin applications.

LANGHORNE, Pa., Jan. 4, 2022 /PRNewswire/ -- NexGel, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a manufacturer of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics, today announced that Adam Levy, Chief Executive Officer of NEXGEL, will participate in the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. Mr. Levy's corporate presentation will be available on-demand starting Monday, January 10th at 7:00 a.m. ET. To attend, register here.

For more information about the H.C. Wainwright conference, please contact your H.C. Wainwright representative directly or KCSA Strategic Communications at NEXGEL@kcsa.com.

About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.

Investor Contacts:
Valter Pinto / Nick Staab
KCSA Strategic Communications
212.896.1254 / 212.896.1254
valter@kcsa.com / nstaab@kcsa.com

Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nexgel-to-present-at-hc-wainwrights-bioconnect-conference-301452894.html

SOURCE NEXGEL

FAQ

When is NexGel's presentation at the H.C. Wainwright Bioconnect Conference?

NexGel's CEO Adam Levy will present at the H.C. Wainwright Bioconnect Conference from January 10-13, 2022.

What time will NexGel's presentation be available?

The presentation will be available on-demand starting January 10, 2022, at 7:00 a.m. ET.

How can I attend the H.C. Wainwright Bioconnect Conference for NexGel?

You can register for the conference here.

What products does NexGel manufacture?

NexGel manufactures high water-content hydrogels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

What is the stock symbol for NexGel?

NexGel is traded under the stock symbol 'NXGL' on NASDAQ.